208 related articles for article (PubMed ID: 30355309)
41. Isolation of monoclonal antibody fragments from phage display libraries.
Arbabi-Ghahroudi M; Tanha J; MacKenzie R
Methods Mol Biol; 2009; 502():341-64. PubMed ID: 19082566
[TBL] [Abstract][Full Text] [Related]
42. Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity.
Seidel-Greven M; Addai-Mensah O; Spiegel H; Chiegoua Dipah GN; Schmitz S; Breuer G; Frempong M; Reimann A; Klockenbring T; Fischer R; Barth S; Fendel R
Malar J; 2021 Jan; 20(1):37. PubMed ID: 33430886
[TBL] [Abstract][Full Text] [Related]
43. Selection of cholera toxin specific IgNAR single-domain antibodies from a naïve shark library.
Liu JL; Anderson GP; Delehanty JB; Baumann R; Hayhurst A; Goldman ER
Mol Immunol; 2007 Mar; 44(7):1775-83. PubMed ID: 17007931
[TBL] [Abstract][Full Text] [Related]
44. Construction of Semisynthetic Shark vNAR Yeast Surface Display Antibody Libraries.
Kolmar H; Grzeschik J; Könning D; Krah S; Zielonka S
Methods Mol Biol; 2023; 2702():227-243. PubMed ID: 37679622
[TBL] [Abstract][Full Text] [Related]
45. Phage Display of Bovine Ultralong CDRH3.
Joyce C; Speight L; Lawson ADG; Scott-Tucker A; Macpherson A
Methods Mol Biol; 2023; 2681():83-97. PubMed ID: 37405644
[TBL] [Abstract][Full Text] [Related]
46. Selection and characterization of naturally occurring single-domain (IgNAR) antibody fragments from immunized sharks by phage display.
Dooley H; Flajnik MF; Porter AJ
Mol Immunol; 2003 Sep; 40(1):25-33. PubMed ID: 12909128
[TBL] [Abstract][Full Text] [Related]
47. Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein.
Chen YL; Lin JJ; Ma H; Zhong N; Xie XX; Yang Y; Zheng P; Zhang LJ; Jin T; Cao MJ
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142819
[TBL] [Abstract][Full Text] [Related]
48. Overview, Generation, and Significance of Variable New Antigen Receptors (VNARs) as a Platform for Drug and Diagnostic Development.
Pandey SS; Kovaleva M; Barelle CJ; Ubah OC
Methods Mol Biol; 2022; 2446():19-33. PubMed ID: 35157267
[TBL] [Abstract][Full Text] [Related]
49. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
50. Selection, identification and crystal structure of shark-derived single-domain antibodies against a green fluorescent protein.
Chen YL; Xie XX; Zheng P; Zhu C; Ma H; Khalid Z; Xie YJ; Dang YZ; Ye Y; Sheng N; Zhong N; Lei WH; Zhang C; Zhang LJ; Jin T; Cao MJ
Int J Biol Macromol; 2023 Aug; 247():125852. PubMed ID: 37460076
[TBL] [Abstract][Full Text] [Related]
51. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
52. Selection of non-aggregating VH binders from synthetic VH phage-display libraries.
Arbabi-Ghahroudi M; MacKenzie R; Tanha J
Methods Mol Biol; 2009; 525():187-216, xiii. PubMed ID: 19252860
[TBL] [Abstract][Full Text] [Related]
53. [Progress in shark single-domain antibody].
Liu X; Chen Q
Sheng Wu Gong Cheng Xue Bao; 2020 Jun; 36(6):1069-1082. PubMed ID: 32597058
[TBL] [Abstract][Full Text] [Related]
54. Characterization and humanization of VNARs targeting human serum albumin from the whitespotted bamboo shark (Chiloscyllium plagiosum).
Li W; Chen M; Wang T; Feng X; Jiang X; Dong X; Zhang H; Tang X; Tian R; Zhang Y; Li Z
Int J Biol Macromol; 2024 Jul; 273(Pt 2):133082. PubMed ID: 38878923
[TBL] [Abstract][Full Text] [Related]
55. The influence of antibody humanization on shark variable domain (VNAR) binding site ensembles.
Fernández-Quintero ML; Fischer AM; Kokot J; Waibl F; Seidler CA; Liedl KR
Front Immunol; 2022; 13():953917. PubMed ID: 36177031
[TBL] [Abstract][Full Text] [Related]
56. A novel shark single-domain antibody targeting OGT as a tool for detection and intracellular localization.
Xi X; Xiao G; An G; Liu L; Liu X; Hao P; Wang JY; Song D; Yu W; Gu Y
Front Immunol; 2023; 14():1062656. PubMed ID: 36855630
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic potential of monoclonal antibodies developed against C-terminal polypeptide of P. falciparum Histidine Rich Protein2 (PfHRP2) in malaria infected patients from India.
Verma R; Chandy S; Jayaprakash NS; Manoharan A; Vijayalakshmi MA; Venkataraman K
Pathog Glob Health; 2017 Sep; 111(6):297-305. PubMed ID: 28777043
[TBL] [Abstract][Full Text] [Related]
58. Assessing Performance of HRP2 Antigen Detection for Malaria Diagnosis in Mozambique.
Plucinski MM; Candrinho B; Dimene M; Colborn J; Lu A; Nace D; Zulliger R; Rogier E
J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31270184
[TBL] [Abstract][Full Text] [Related]
59. Single-chain antibody fragment specific for Plasmodium vivax Duffy binding protein.
Kim SH; Hwang SY; Lee YS; Choi IH; Park SG; Kho WG
Clin Vaccine Immunol; 2007 Jun; 14(6):726-31. PubMed ID: 17460118
[TBL] [Abstract][Full Text] [Related]
60. Humanization of the Shark V
Zhang YF; Sun Y; Hong J; Ho M
Curr Protoc; 2023 Jan; 3(1):e630. PubMed ID: 36594750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
